Moorestown, New Jersey, United States
novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV
What have we learned after a two-year pandemic? | COVID-19 Special
Jun 11, 2022 DW News
The new Omicron subvariant BA.5 has triggered a rise in infections in Portugal. But in many countries, the pandemic appears to be leveling off. What have we learned over the last two years? We find out - in this week's COVID-19 Special.
How long does Covid immunity last? Will a second illness be worse? Some reinfection questions, answered.
This Chemical Can Impair Fertility, but It’s Hard to Avoid
Australia’s Early Flu Season Shows Americans Need Their Shots
China Is Walking Back Virus Loosening Just Weeks After Reopening
As the U.S. confronts its largest-ever monkeypox outbreak, public health authorities navigate a delicate but familiar balancing act.By Fenit Nirappil
By Dan Keating, Madison Dong and Youjin Shin
Starting Sunday, international travelers flying to the United States will no longer need to show proof of a negative coronavirus test before boarding their flights, the Biden administration said Friday
By Lori Aratani
Reckitt Benckiser and startups such as ByHeart and Bobbie are picking up customers but market-share gains could be tough to keep.
Three doses of the Covid-19 vaccine from Pfizer and BioNTech were effective at preventing symptomatic disease in children ages 6 months through 4 years in studies, according to U.S. health regulators.
Centralized quarantine has been halved to seven days plus another seven in self-isolation for those from medium and high-risk areas
Jun 11, 2022 06:48 PM
Move adds to concerns that China’s Covid Zero strategy may send cities into repeated lockdowns and re-openings
Jun 11, 2022 06:14 PM
Rebound of infections Thursday and Friday force renewed measures as Beijing also goes on alert amid flare-ups including a local bar
Jun 11, 2022 05:30 AM
Even as demand grows ever higher, government price cuts and tougher competition mean profits are harder to come by
Jun 10, 2022 09:05 PM
Falsified results and negligent handling of samples are undermining the city’s month-long anti-Covid efforts, authorities say
Jun 10, 2022 08:02 PM
Health official He Qinghua says local authorities should prioritize groups with a high risk of getting infected
Jun 10, 2022 07:22 PM
Travel firms in confusion as Japan reopens to foreign tourists
Will Indonesia’s quality tourism plan push out local visitors from Borobudur?
Covid-19 cases top 800, imported ones surpass 100 for first time in Hong Kong
Health officials confirm 814 infections, down slightly from 851 recorded on Saturday.
12 Jun 2022 - 11:22PM
Some monkeypox patients also have sexually transmitted diseases, CDC says
Spencer Kimball FRI, JUN 10TH 2022
China struggles to stamp out Covid as cities reimpose some restrictions
Evelyn Cheng FRI, JUN 10TH 2022
Diseases suppressed during Covid are coming back in new and peculiar ways
Karen Gilchrist FRI, JUN 10TH 2022
Travel industry urges end to Covid-19 testing requirement for foreign travelers
Seema Mody THU, JUN 9TH 2022
Signs point to biotech M&A heating up, Wells Fargo says. Here’s where to look
Christina Cheddar Berk THU, JUN 9TH 2022
US, new omicrons
Jun 8, 2022 Dr. John Campbell
And is virus blowing in the Asian wind? US https://covid.cdc.gov/covid-data-trac... BA 4, 5.4% BA 5, 7.6% BA.4 and BA.5, first detected in South Africa, early 2022 Now, at 13% of cases Last week, 7.5% of cases Probably mostly immune escape UK https://www.gov.uk/government/publica... https://www.gov.uk/government/publica... Last 90 days (updated 7th June) BA.1, 2,175508 BA.2, 469,309 XE, 2,009 BA.4, 289 BA.5, 219 ONS https://www.ons.gov.uk/peoplepopulati... Percentage of the community population that had COVID-19 1.44% in England (1 in 70 people) 1.30% in Wales (1 in 75 people) 1.33% in Northern Ireland (1 in 75 people) 2.01% in Scotland (1 in 50 people) Long covid, UK, as of 1st May 2022 2.0 million 3.1% of the population 72% for at least 12 weeks 42% at least one year 19% at least two years Symptoms Fatigue 55% Shortness of breath 32% cough 23% muscle ache 23% Symptoms adversely affected the day-to-day activities 1.4 million people (71% of those with self-reported long COVID). More LC after delta than omicron (in double-vaccinated people) Self-reported long COVID was almost twice as common after Delta than after Omicron BA.1 infections North Korea https://www.nytimes.com/2022/06/07/op... Dr. Mike Ryan we have real issues in getting access to the raw data and to the actual situation on the ground It is very, very difficult to provide a proper analysis to the world when we don’t have access to the necessary data Extensive use of Sinovac Jean H. Lee Chronic food shortages Since a massive famine in the 1990s Fruit, vegetables and meat are luxuries Malnutrition shows, splotchy skin, sunken cheekbones, gaunt frames Most hospitals and clinics do not have heat, medicine or supplies North Korean nurses washing syringes Doctors and patients bundle up in quilted jackets One North Korean doctor, relied on preventive care because she had no medicine, not even for diarrhea, which she said kills scores of North Korean children every year North Koreans living in mountainous areas China https://coronavirus.jhu.edu/region/china Cases, 2,101,049 Deaths, 14,615 Fully vaccinated, 89.05% Doses administered 3.5 billion Government notice, Dandong https://mp.weixin.qq.com/s/90KdrMD4Gc... https://www.bloomberg.com/news/articl... try not to open windows in southerly weather for residents along the river, and do not disperse pigeons during the epidemic Airborne transmission of respiratory viruses https://www.science.org/doi/10.1126/s... Long-range airborne transmission of SARS-CoV-2 has been observed, hotel quarantines, in a large church Half live of virus in aerosols One to to 3 hours SARS-CoV and SARS-CoV-2 (laboratory-generated aerosols)
Moderna's new Covid booster provides superior protection against omicron
Jun 8, 2022 CNBC Television
NBC's Meg Tirrell joins 'Squawk Box' to break down Moderna's latest data surrounding its combo Covid-19 booster aimed at protecting against omicron and the original strain of the virus.
Coronavirus cases on the rise in Shelby County
Jun 9, 2022 WREG News Channel 3
Coronavirus cases are on the rise across the country and Shelby County is averaging more cases than it has seen in months.
Shanghai’s Lockdown Punctured the Chinese Dream CONNIE MEI PICKART
A Chinese Entrepreneur Who Says What Others Only Think
If all goes as expected, two vaccines — one by Moderna, the other by Pfizer and its German partner, BioNTech — will be authorized by federal authorities and be available by June 21. By Lena H. Sun and Laurie McGinley
By Kim Bellware and Lenny Bernstein
Inflation remained benign in China as Covid-19 lockdowns hammered domestic demand, leading economists to forecast that policy makers may ramp up stimulus to boost economic growth and employment.
Health official He Qinghua says local authorities should prioritize groups with a high risk of getting infected
Jun 10, 2022 07:22 PM
Onshore yuan trading volumes bounced off two-year lows while stock turnover topped $149 billion for two straight sessions this week
Jun 10, 2022 05:11 PM
Shanghai Heightens Covid Restrictions After a Spike in Cases Sparks Concern
May shipments surge 16.9% amid easing of production and logistics bottlenecks as authorities lift Covid restrictions
Jun 10, 2022 04:10 AM
Shanghai warns public to avoid crowds as it prepares for mass Covid-19 test
Why did so many Beijing restaurants remain empty after reopening this week?
Chinese biotech firms seeking to enter US face rising scrutiny, says analyst
China tries to calm jittery investors after shock of Shanghai lockdown
10 Jun 2022 - 9:00AM
How Hong Kong’s new Covid case reporting criteria affects you
Philadelphia is at a medium COVID-19 level, according to the CDC. The new case rate has risen 4% in the last two weeks.
Why is China sticking to its zero-COVID policy? | DW News
Jun 8, 2022 DW News
More than two years into the pandemic, China is still sticking to its zero-COVID strategy, while the rest of the world has moved toward living with the virus. Here's why.
FDA advisory group recommends Novavax Covid vaccine
sJun 7, 2022 NBC Television
CNBC's Meg Tirell joins 'Closing Bell' to report on the FDA advisory group's recommendation of the Novavax Covid vaccine, making it the U.S. fourth vaccine.
Ukraine War creating “global food crisis” says world trade body - BBC News
Jun 8, 2022 BBC News
The war in Ukraine is creating a disastrous crisis in the world’s food supplies that could last for years, according to the World Trade Organisation. Ukraine is a major global exporter of wheat, contributing 9% of the global market. It accounts for a massive 42% of the global sunflower oil market and 16% of the world's maize. However millions of tonnes of grain are sitting in warehouses and Ukrainian ports unable to be exported due to the war. African countries are being hit especially hard by wheat and fertilizer shortages, according to the WTO Director-General Ngozi Okonjo-Iweala.
Global Food Import Bill Set for Record, Taking Toll on Poore
The Formula Crisis Takes an Economic Toll on Families in Gas Money and Wasted Hours
The shortage comes as inflation is squeezing household budgets, and hits low-wage workers especially hard.
Pandemic updates: The White House said it must shift funds from testing to buy more vaccines and treatments.
A Vanishing Word in the Abortion Debate: ‘Women’
Vaccinations could begin later in June if shots from Moderna and Pfizer are authorized by the Food and Drug Administration.
Abbott Laboratories received a complaint filed by a former employee concerning problems at an infant-formula plant months earlier than previously publicly known, according to a government official, a person familiar with the matter, and documents viewed by The Wall Street Journal.
Two Georgia-based institutions are first to be hit with fines in connection with federal rules that took effect in 2021.
The surge, which was bigger than economists were expecting, suggests overseas orders for Chinese goods had piled up during previous months when pandemic measures shut factories and port traffic collapsed.
After six months of an experimental treatment, tumors vanished in all 14 patients diagnosed with early stage rectal cancer who completed the study before its publication.
By Kim Bellware
By Yasmeen Abutaleb and Andrew Jeong
If all goes as expected, two vaccines — one by Moderna, the other by Pfizer and its German partner, BioNTech — will be authorized by federal authorities and be available by June 21.
By Lena H. Sun and Laurie McGinley
‘No chance’ of reopening border with mainland, city logs 674 Covid-19 cases
Chief executive for the first time concedes city caught ‘in the middle’ of differing Covid-19 policies between China and other jurisdictions.
Xi tour highlights modern farmland role to boost China’s food security
Coronavirus: Japan’s outdoor mask relaxation yet to filter through
Japan braces for surge of travel-starved visitors after ‘dark two years’
The city reimposes lockdowns on some residential neighborhoods after determining the virus is once again spreading outside quarantined areas
Jun 08, 2022 08:19 PM
Dr. Scott Gottlieb on promising new cancer drug data: 'The future is here'
Jun 6, 2022 CNBC Television
Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins CNBC's 'Squawk Box' to discuss the top drug trial data coming out of the American Society of Clinical Oncology conference in Chicago.
Beijing eases Covid restrictions, requires 72-hour tests for most business activity
Jun 6, 20221 CNBC Television
CNBC's Eunice Yoon joins 'Squawk Box' from Beijing to break down how the city is moving to lift its stringent Covid-19 restrictions.
#erinburnettoutfront #CNN #News
'Tumors just vanished': Cancer patients now in remission after drug trial
Jun 6, 2022 CNN
Treatment with the immunotherapy dostarlimab showed promising results in a small trial of more than a dozen rectal cancer patients, according to new research, but further study is needed and it is too early to call it a cure. CNN's Erin Burnett speaks to Dr. Andrea Cercek, an oncologist at Memorial Sloan Kettering Cancer Center. #erinburnettoutfront #CNN #News
By Linda Searing
By Andrew Jeong
The Novavax vaccine is a protein vaccine, a more traditional technology found in other commonly used immunizations such as hepatitis B and influenza.
By Carolyn Y. Johnson and Laurie McGinley
By Dan Keating, Madison Dong and Youjin Shin
The experimental vaccine, designed to fight Omicron as well as the original virus, was found to be more effective against the new variant than the currently available shot.
Moderna said that new trial results showed that a revised version of its vaccine worked better against Omicron.
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival Rates
What next for China’s zero-Covid policy after Shanghai lockdown?
Subtle changes have been introduced to prevent widespread closures but the reliance on PCR testing has huge costs.
Tesla’s Shanghai plant to exit ‘closed loop’ as Covid-19 fears ease
Tourists to Japan may be sent home if they don’t wear face masks
Science No link between Covid infection risk and asthma, study finds
The city reimposes lockdowns on some residential neighborhoods after determining the virus is once again spreading outside quarantined areas
Moderna says its updated COVID vaccine boosts protection against Omicron
My beloved doctor is retiring, and now I need to find a new physician. I’m not alone.
Although one survey found that the vast majority of doctors (96%) said they won’t leave medicine because of the pandemic, another said 22% are thinking about retiring early.
Dawn Fallik
08 June, 2022 MRNA-1273.214
Download PDF(OPENS IN NEW WINDOW)
Moderna says booster targeting Omicron outperformed current vaccine
Jun. 08, 2022 7:28 AM ETModerna, Inc. (MRNA)By: Dulan Lokuwithana, SA News Editor4 Comments
https://seekingalpha.com/symbol/MRNA
Evusheld significantly prevented COVID-19 disease progression or death in TACKLE Phase III treatment trial
PUBLISHED 8 June 2022 8 June 2022 07:00 BST
Results published in The Lancet Respiratory Medicine support benefits of Evusheld in the outpatient treatment of mild-to-moderate COVID-19
Detailed results from the TACKLE Phase III outpatient treatment trial showed AstraZeneca’s Evusheld (tixagevimab and cilgavimab, formerly AZD7442) provided clinically and statistically significant protection against progression to severe COVID-19 or death from any cause compared to placebo, with treatment with Evusheld earlier in the disease course leading to more favourable outcomes.1
The data have been published in The Lancet Respiratory Medicine.
ABOUT EVUSHELD
https://www.evusheld.com/en/patient
Shanghai residents confront officials after swift return of lockdown
Jun 6, 2022 South China Morning Post
Nearly a week after Shanghai reopened, residents in Xuhui district were outraged when lockdowns were quickly reimposed. Crowds demanded answers from officials on the other side of the barrier and chanted “Serve the people!”
The coronavirus pandemic has created a mass-disabling event that experts liken to HIV, polio or World War II, with millions suffering the long-term effects of infection with the coronavirus.
The National Institutes of Health should improve its oversight of federal grant recipients who do sensitive medical research and whose scientists receive foreign funding or support, according to a new report.
California’s latest COVID-19 surge may be slowing, early data suggest
Suspected monkeypox cases rise in California; officials expect more to come
As I See It | Lockdowns and June 4 amnesia – why Beijing isn’t ready for Chinese century
Tourists to Japan may be sent home if they don’t wear face masks
Revenge travel’: Singapore airfares up 27 per cent on pre-pandemic levels
No link between Covid infection risk and asthma, study finds
Health & Wellness10 summer health tips from Ayurveda experts to battle excess body heat
Explained‘Hell on earth’: can the world spend its way out of the global food crisis?
Covid: Why do some vaccines protect you for longer than others?
https://www.bbc.com/news/av/health-61604996
Parks and restaurants welcomed people again as citywide test interval extended to 72 hours
- Beijing Says Outbreak Under Control as City Eases Curbs
- As Beijing Loosens Covid Curbs, One District Locks Down
A new mental health emergency number launches in July. Some hope 988 is a catalyst for bigger change
Merck and Ridgeback Announce New Data For Investigational LAGEVRIO™ (molnupiravir) From Phase 3 MOVe-OUT Study
June 7, 2022 6:45 am ET
Based on Prespecified Exploratory Endpoints, a Lower Proportion of Participants Treated With LAGEVRIO Had an Acute Care Visit Compared to Those Who Received Placebo
Based on a Post Hoc Analysis, Fewer Required Respiratory Interventions (Including Invasive Mechanical Ventilation)
RAHWAY, N.J. & MIAMI--(BUSINESS WIRE)-- Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced the Annals of Internal Medicine has published additional data from the Phase 3 MOVe-OUT trial evaluating LAGEVRIO™ (molnupiravir), an investigational oral antiviral medicine, in non-hospitalized adults with mild to moderate COVID-19 who were at high risk for progressing to severe disease.
- LAGEVRIO™ (molnupiravir) is an investigational medicine used to treat mild-to-moderate COVID-19 in adults:
- with positive results of direct SARS-CoV-2 viral testing, and
- who are at risk for progression to severe COVID-19 including hospitalization or death, and for whom other COVID-19 treatment options approved or authorized by the FDA are not accessible or clinically appropriate
https://www.molnupiravir-us.com/patients/
FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and OlderJun 7, 2022
- Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee
- If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the first protein-based COVID-19 vaccine available in the U.S.
GAITHERSBURG, Md., June 7, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 21 to 0, with one abstention, to recommend that the FDA grant Emergency Use Authorization (EUA) for the Novavax COVID-19 vaccine (NVX-CoV2373) for individuals aged 18 years and over.
The VRBPAC considered data from the pivotal Phase 3 clinical trial, PREVENT-19, which enrolled approximately 30,000 participants aged 18 years and older in the U.S. and Mexico and was published in the New England Journal of Medicine. In the trial, the Novavax COVID-19 vaccine demonstrated 90.4% efficacy (95% confidence interval [CI], 82.9 to 94.6; P<0.001) with a reassuring safety profile.
https://seekingalpha.com/symbol/NVAX
Slow take-up for recently approved COVID-19 oral pills
Jun 3, 2022 CNA
At least two clinics have said that the take-up has been slow for recently approved COVID-19 medication. They said that not many patients are eligible for the antiviral drug known as Paxlovid, and among those who are eligible, several have declined. Some patients said that mild symptoms negate the need, while a few have reported side effects. Dale Fisher, Professor of Medicine at the NUS Yong Loo Lin School of Medicine and Chair of the Global Outbreak Alert and Response Network at WHO, shared his thoughts on this.
PAXLOVID™ (nirmatrelvir and ritonavir)
https://www.pfizer.com/products/product-detail/paxlovidtm
The key to this household mystery may lie in a person’s vaccination status, experts say.
The latest virus wave is showing signs of abating in the Northeast of the United States.
Coronavirus updates: Beijing relaxed its Covid measures as fears of another outbreak lingered.
The Novavax vaccine has been long awaited by some people allergic to the other shots. By Carolyn Y. Johnson
The pandemic has created a mass-disabling event that experts liken to HIV, polio or World War II. By Frances Stead Sellers
AstraZeneca Breast-Cancer Drug Shown to Slow Tumor Progression
Beijing Cautiously Reopens After Covid-19 Wave
China’s capital lifted restrictions on dining in restaurants and many workers returned to their offices, but new Covid-19 flare-ups around the country and fresh lockdowns in parts of Shanghai continue to pose risks to the economy.
Covid-19 curbs continue to haunt Chinese tourism over Dragon Boat Festival
Analysis | How the economic slowdown and zero-Covid threaten China’s global plans
- Premier Li Keqiang’s recent warning that the economy is struggling to stay on track may have a knock-on effect on its global investment plans
- Some observers say the prospect of a slowdown will also hamper Beijing’s efforts to present itself as an alternative to the US
Singapore should prepare for new Covid wave in July or August, minister says
Shanghai outbreak exposes Chinese health system’s fragility
Covid cases shut down Chinese city as Beijing, Shanghai return to new normal
6 Jun 2022 - 6:07PM
Parks and restaurants welcomed people again as citywide test interval extended to 72 hours
- Beijing Says Outbreak Under Control as City Eases Curbs
- As Beijing Loosens Covid Curbs, One District Locks Down
“With my mother’s history, I just wanted to be proactive,” Andrea Cronin said. “My doctor suggested alternating mammograms and MRIs every six months.”
Terri Akman, For The Inquirer
The U.S. has wasted over 82 million Covid vaccine doses
Vaccine providers say declining demand, large minimum orders and multidose vials make it hard to avoid waste while still offering shots to anyone who wants them.
June 6, 2022, 4:27 AM EDT By Joshua Eaton
https://www.nbcnews.com/news/us-news/covid-vaccine-doses-wasted-rcna31399
U.S. has thrown away 82M COVID-19 vaccine doses - NBC News
Jun. 06, 2022 1:39 PM ET Walmart Inc. (WMT), COST, CVS, PFEWBA, DVA, RAD, MRNA, BNTX
By: Jonathan Block, SA News Editor41 Comments
From December 2020 through May 2022, more than 82M COVID-19 doses were discarded, NBC News reported, based on data from the CDC.
https://seekingalpha.com/news/3846025-us-has-thrown-away-82m-covid-19-vaccine-doses-nbc-news
Novavax faces high-stakes FDA review this week to decide the fate of its Covid shots in the U.S.
Spencer Kimball
U.S. has 36,000 Jynneos monkeypox vaccine doses in national stockpile
Spencer Kimball
Monkeypox may have been spreading ‘under the radar’ for months or years
NBC NEWS SUN, JUN 5TH 2022
Abbott Nutrition restarts baby formula production in reopened Michigan plant
Kate Dore, CFP® SAT, JUN 4TH 2022
The CDC is sending monkeypox vaccines to people at high risk of exposure
Spencer Kimball